Qian and colleagues illustrated in a breast cancer model that CCL2 synthesized by metastatic tumor cells recruits CCR2-expressing monocytes, while inhibition of CCL2 markedly reduces the number of TAMs found in lung metastases11. Here, CCR2 is linked to breast carcinoma.